U.S., March 26 -- ClinicalTrials.gov registry received information related to the study (NCT06892639) titled 'Evaluation of D-Fi for the Treatment of Wounds Due to DEB' on March 12.
Brief Summary: The purpose of this study is to determine whether administration of D-Fi in addition to standard of care improves wound healing as compared to standard of care alone (control) in children, adolescents, and adults with Dystrophic Epidermolysis Bullosa.
Study Start Date: March, 2025
Study Type: INTERVENTIONAL
Condition:
Dystrophic Epidermolysis Bullosa
Intervention:
BIOLOGICAL: D-Fi
D-Fi is composed of fibroblasts isolated from the subject's skin biopsies which are genetically corrected with the full length COL7A1 gene encoding for type VII ...